Promotion_AntibodySystem

Home / Information / Promotion

Information

Information Close

Promotion

10
2026-09

Chikungunya Virus (CHIKV)

Comprehensive resource on Chikungunya virus (CHIKV): E1, E2, Capsid, nsP1-nsP4 proteins, antibodies, recombinant antigens, and research products from AntibodySystem.

More
08
2026-09

Treponema pallidum (TP/Syphilis)

Comprehensive resource on Treponema pallidum: Tp15, Tp17, Tp47, TprK, TprC/TprD, BamA proteins, antibodies, recombinant antigens, and ELISA kits from AntibodySystem.

More
03
2026-09

Bovine Viral Diarrhea Virus (BVDV)

BVDV, Bovine Viral Diarrhea Virus, E2, Erns, Npro, NS2, NS3, NS5B, antibody, vaccine, antigen, pestivirus, AntibodySystem

More
02
2026-09

Rabies Virus (RABV)

Comprehensive resource on Rabies virus (RABV): glycoprotein G, nucleoprotein N, phosphoprotein P, matrix protein M, large protein L, antibodies, recombinant antigens, and ELISA kits from AntibodySystem.

More
01
2026-09

African Swine Fever Virus (ASFV)

Comprehensive overview of African Swine Fever Virus (ASFV) structure, key antigenic targets (p72, p54, p30, p17, CD2v), and research products from AntibodySystem

More
24
2026-08

Monkeypox Virus, MPXV

Comprehensive resource on Mpox virus (MPXV): A35R, A29L, M1R, B6R, E8L, F3L protein structure, antibody targets, vaccine research, and products from AntibodySystem

More
18
2026-08

Influenza Virus (Flu)

Comprehensive resource on Influenza virus: HA, NA, M2e, NP, M1/M2, polymerase proteins, neutralizing antibodies, vaccine targets, and research products from AntibodySystem.

More
17
2026-08

Human Respiratory Syncytial Virus, HRSV

Comprehensive resource on HRSV: F/G/N/M/L protein structure, prefusion/postfusion conformations, neutralizing antibody epitopes, vaccine antigen design, and research products from AntibodySystem

More
24
2026-04

In Vivo Antibodies Flat Price Promotion

More
27
2026-03

Tumor-Associated Macrophages: From Depletion Failure to Functional Reprogramming in Cancer Immunotherapy

Tumor-associated macrophages (TAMs) have long been regarded as key drivers of immunosuppression within the tumor microenvironment (TME), making them an attractive therapeutic target. Early strategies largely focused on reducing TAM abundance, under the assumption that their elimination would relieve immune suppression and enhance anti-tumor immunity.

More
07
2026-01

From hPSCs to Neurons: A Beginner-Friendly Guide to Growth Factor–Driven Differentiation Logic

For researchers new to hPSC-based neural differentiation, the most common challenge is not technical execution, but understanding why specific factors are added at each stage. At its core, neural differentiation of human pluripotent stem cells is a process of artificially recreating defined signaling environments, allowing cells to receive the right developmental cues at the right time. Understanding the function of these cues is far more important than memorizing differentiation recipes.

More
22
2025-04

New Product | ELISA KIT: When ELISA Meets HPV 16/18 E6/E7, A Protein Tracking Drama is About to Unfold

Cervical cancer ranks as the fourth most common cancer among women globally and is caused by persistent infection with the Human Papillomavirus (HPV), a small DNA virus known to infect the skin, genital areas, and throat. Based on disease severity, HPV is categorized into low-risk and high-risk types. Persistent infection with high-risk HPV, particularly types 16 and 18, is responsible for 70% of cervical cancer cases due to their potential to cause malignant tumors.

More

Terms of sale Website terms of use Cookie policy Privacy

Copyright © 2026 AntibodySystem All Rights Reserved. All Products are for Research Use Only